Literature DB >> 28011413

A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.

Omolbanin Amjadi1, Alireza Rafiei2, Mohammadreza Haghshenas3, Reza Alizadeh Navaei1, Reza Valadan1, Zahra Hosseini-Khah4, Akbar Hedayatizadeh Omran5, Mohsen Arabi6, Reza Jafari Shakib7, Tahoora Mousavi1, G Hossein Ashrafi8.   

Abstract

Varicella zoster virus (VZV) causes chicken pox as a primary infection following which it becomes latent in neurons. It may then reactivate to cause shingles (herpes zoster). Severity of lesions and VZV pathogenicity are depended on the host's immune response and variant in VZV Dr Athina Myrto ChioniIdentification of VZV seroprevalance rate in general population may lead to develop new health strategic managements such as vaccination. Therefore, we aimed to provide a systematic review of the seroprevalence of VZV infection among Iranian population and estimate age- and gender- specific prevalence of VZV. Keywords "seroprevalence"; "varicella zoster virus" and "Iran"; were searched in international electronic databases and also in national Persian databases. Twenty two pooled studies among 262 total studies containing (240 published articles; 18 dissertations; and 4 proceedings abstracts) from 1992 to 2014 with total sample size of 7867 individuals were included in the final review. Data was analyzed using random effect method. The heterogeneity was calculated using I-square statistics The overall IgG seroprevalence rate of VZV infection in general population of Iran was 78.50% (95% CI; 77.74%-79.25%). There was significant heterogeneity among the studies (P<0.0001; I2=99.4%). Furthermore, the relative risk of VZV infection is high in females (80.47%, 95% CI; 79.40%-81.54%) and older adults (95.30%, 95% CI; 94.11% -96.48%). Our results may represent a true background and estimation of VZV infection in Iran and generate the cost-benefits immunization program. Moreover, the ensuing data suggests further attention on disease seroprevalence in order to obtain efficient data for therapeutic intervention targeted against VZV.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IgG; Immunity; Iran; Seroprevalence; Vaccination; Varicella zoster virus

Mesh:

Substances:

Year:  2016        PMID: 28011413     DOI: 10.1016/j.jcv.2016.12.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

1.  Uptrend prevalence of varicella parallel with low serum antibodies and low second-dose rate among children 10-14 years old in Wenzhou, China.

Authors:  Qi Liu; Jiake Yu; Jingjiao Wei; Hu Zhang; Jie Jin; Weikun Zheng; Yufei Ruan; Jinsheng Yu; Yiping Chen
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

2.  Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China.

Authors:  Lei Zhang; Wang Ma; Yuanbao Liu; Yong Wang; Xiang Sun; Ying Hu; Xiuying Deng; Peishan Lu; Fenyang Tang; Zhiguo Wang; Minghao Zhou
Journal:  BMC Infect Dis       Date:  2018-11-14       Impact factor: 3.090

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 4.  Video Anthology of Movement Disorders Due to Infections in South Asia.

Authors:  Annu Aggarwal; Sachin Adukia; Mohit Bhatt
Journal:  Mov Disord Clin Pract       Date:  2021-07-18

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Seropositivity, Risks, and Morbidity From Varicella-Zoster Virus Infections in an Adult PWH Cohort From 2000-2020.

Authors:  Jason Zou; Hartmut B Krentz; Raynell Lang; Brenda Beckthold; Kevin Fonseca; M John Gill
Journal:  Open Forum Infect Dis       Date:  2022-08-09       Impact factor: 4.423

7.  The clinical and economic burden of varicella in the Middle East: a systematic literature review.

Authors:  Nawal Al Kaabi; Fatma Mohd Ali Sultan Al Olama; Mamoun Al Qaseer; Idris Al Ubaidani; Ener Cagri Dinleyici; Wail Ahmad Hayajneh; Abdul Rahman Bizri; Maysoon Loulou; Tidiane Ndao; Lara J Wolfson
Journal:  Hum Vaccin Immunother       Date:  2019-09-03       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.